Telehealth Treatment for Alcohol Use Disorder

Last updated: June 12, 2024
Sponsor: Ria Health
Overall Status: Active - Recruiting

Phase

N/A

Condition

Alcohol Dependence

Alcohol Use Disorder

Addictions

Treatment

Ria Treatment Platform

Clinical Study ID

NCT05747703
1A
  • Ages > 18
  • All Genders

Study Summary

Participants with alcohol use disorder will be randomly assigned to either the Ria Treatment Platform or a waitlist control. The Ria Treatment Platform is a telehealth approach that incorporates medical assessment, medications for alcohol use disorder, individual and group coaching, educational video modules, and a Bluetooth-enabled breathalyzer. Patients are followed for three months during which data are collected, including measures of alcohol consumption and its consequences.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • alcohol use disorder

Exclusion

Exclusion Criteria:

  • inability to provide informed consent

Study Design

Total Participants: 124
Treatment Group(s): 1
Primary Treatment: Ria Treatment Platform
Phase:
Study Start date:
January 31, 2024
Estimated Completion Date:
September 30, 2025

Connect with a study center

  • Stanford University

    Stanford, California 94305
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.